Miguel A Hernán Selected Research

Heart Failure

1/2020	Adherence-adjustment in placebo-controlled randomized trials: An application to the candesartan in heart failure randomized trial.
1/2018	Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel A Hernán Research Topics

Disease

23	Acquired Immunodeficiency Syndrome (AIDS) 11/2019 - 06/2002
18	COVID-19 01/2022 - 01/2020
11	Infections 06/2022 - 08/2011
7	Parkinson Disease (Parkinson's Disease) 10/2007 - 09/2002
6	Coronary Disease (Coronary Heart Disease) 01/2022 - 11/2008
4	Neoplasms (Cancer) 10/2020 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2018 - 11/2011
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 04/2005
4	Multiple Sclerosis 06/2006 - 09/2004
3	Myocardial Infarction 01/2022 - 11/2011
3	Hemorrhage 01/2021 - 08/2011
3	Critical Illness (Critically Ill) 01/2021 - 11/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2010
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2019
2	Heart Failure 01/2020 - 01/2018
2	Drug Overdose 03/2019 - 01/2019
2	AIDS Dementia Complex 01/2018 - 07/2014
2	Anemia 01/2014 - 04/2007
2	Type 2 Diabetes Mellitus (MODY) 05/2013 - 01/2013
2	Rheumatoid Arthritis 11/2011 - 04/2002
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2006 - 09/2005
2	Congenital Abnormalities (Deformity) 08/2003 - 01/2002
1	Reinfection 06/2022
1	Ischemic Stroke 01/2022
1	Premature Birth (Birth, Premature) 01/2022
1	Thyroid Diseases (Thyroid Disease) 01/2022
1	Infertility (Sterility) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Heart Diseases (Heart Disease) 01/2021
1	Myocarditis (Carditis) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Cytokine Release Syndrome 01/2021
1	ST Elevation Myocardial Infarction 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Hepatitis C 01/2020
1	Adenocarcinoma 01/2020
1	Weight Gain 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2022 - 01/2014
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020 - 02/2012
5	Estrogens (Estrogen)FDA Link 01/2020 - 09/2005
5	RNA (Ribonucleic Acid)IBA 11/2019 - 05/2012
4	BNT162 VaccineIBA 01/2022 - 12/2021
4	Pharmaceutical PreparationsIBA 01/2020 - 04/2007
4	efavirenz (Sustiva)FDA Link 01/2018 - 08/2012
3	mRNA VaccinesIBA 06/2022 - 12/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
3	AntibodiesIBA 11/2021 - 01/2020
3	Zidovudine (Retrovir)FDA LinkGeneric 01/2018 - 06/2002
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 04/2015
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2011 - 08/2003
3	Progestins (Progestagens)IBA 07/2010 - 11/2008
2	LDL CholesterolIBA 01/2022 - 10/2020
2	2019-nCoV Vaccine mRNA-1273IBA 01/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 11/2021 - 11/2020
2	Emtricitabine (Emtriva)FDA Link 10/2020 - 01/2018
2	RacivirIBA 10/2020 - 01/2018
2	Tenofovir (Viread)FDA Link 10/2020 - 01/2018
2	Lamivudine (Epivir)FDA Link 10/2020 - 01/2018
2	Reverse Transcriptase InhibitorsIBA 10/2020 - 08/2012
2	Nevirapine (Viramune)FDA Link 01/2018 - 08/2012
2	Lopinavir FDA Link 01/2018 - 04/2015
2	Uric Acid (Urate)IBA 03/2016 - 10/2007
2	Coffee FDA Link 01/2013 - 09/2002
2	Methotrexate (Mexate)FDA LinkGeneric 11/2011 - 04/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2011 - 06/2006
2	Biological ProductsIBA 12/2006 - 04/2005
2	Folic Acid (Vitamin M)FDA LinkGeneric 08/2004 - 01/2002
1	Clomiphene (Clomifene)FDA LinkGeneric 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	HDL CholesterolIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	bivalirudin (Angiomax)FDA Link 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	tenofovir alafenamideIBA 10/2020
1	abacavir (Ziagen)FDA Link 10/2020
1	LipidsIBA 10/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	candesartanIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Gemcitabine FDA Link 01/2020

Therapy/Procedure

32	Therapeutics 01/2021 - 04/2002
7	Highly Active Antiretroviral Therapy (HAART) 08/2012 - 10/2003
4	Renal Dialysis (Hemodialysis) 01/2018 - 04/2007
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2021
2	Diet Therapy (Therapy, Diet) 01/2020 - 01/2020
1	Extracorporeal Membrane Oxygenation 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Art Therapy 10/2020